Intellia Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4)
NTLA•Intellia Therapeutics reported inducement grants under Nasdaq Listing Rule 5635(C)(4).
1. Inducement grants
Intellia Therapeutics reported inducement grants under Nasdaq Listing Rule 5635(C)(4).
